Moody Lynn & Lieberson, LLC Astrazeneca PLC Transaction History

Moody Lynn & Lieberson, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$66.81 - $80.83 $2.22 Million - $2.69 Million	33,249 New	33,249 $2.59 Million
Q2 2022 Jul 28, 2022	SELL	$59.26 - $71.14 $79,408 - $95,327	-1,340 Reduced 1.55%	85,188 $5.63 Million
Q1 2022 Apr 27, 2022	BUY	$55.72 - $67.12 $1.46 Million - $1.76 Million	26,290 Added 43.64%	86,528 $5.74 Million
Q4 2021 Jan 26, 2022	BUY	$54.02 - $63.83 $3.25 Million - $3.84 Million	60,238 New	60,238 $3.51 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.